Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes

Original Article

R. Agarwal, J.B. Green, H.J. Heerspink, J.F. Mann, J.B. McGill, A.K. Mottl, J. Rosenstock, P. Rossing, M. Vaduganathan, M. Brinker, R. Edfors, N. Li, M.F. Scheerer, C. Scott, and M. Nangaku

N Engl J Med 2025;393:533-543

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
08/06/2025
Course expires: 
08/07/2027

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.